• PDF / 167,340 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 41 Downloads / 211 Views

DOWNLOAD

REPORT

1173-5503/20/0866-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 14 Nov 2020 No. 866

1

Recommend Documents

Olaparib cost effective for advanced BRCA -associated ovarian cancer

145 30 168KB

Trastuzumab cost effective in early breast cancer

115 43 122KB

Preoperative lymphoscintigraphy cost effective in vulvar cancer

157 31 166KB

Advanced post-mastectomy radiotherapy cost effective in US

136 104 182KB

Pegfilgrastim more cost effective than filgrastim in breast cancer

105 70 124KB

Capecitabine + irinotecan cost effective for colorectal cancer in China

154 88 163KB

Which oesophageal cancer screening strategy is cost effective in China?

144 60 163KB

Is LV dysfunction screening in childhood cancer survivors cost effective?

179 0 163KB

Childhood cancer therapies cost effective in sub-Saharan Africa

148 45 167KB

70-gene signature cost effective in guiding breast cancer therapy

114 17 184KB

MicroRNA-based screening cost effective in diagnosing gastric cancer

153 59 182KB

Atorvastatin cost effective in T2DM

163 57 182KB